You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Breast Tumor

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

IMpact of Breast cAncer Gene Status on Survival in Adjuvant

Completed
  • Breast Cancer
  • +2 more
  • BRCA mutation
  • Besançon, Franche-Comté, France
    University Hospital Jean Minjoz
Jul 8, 2019

Advanced Solid Tumor Trial in Beijing (APL-102 Capsules)

Recruiting
  • Advanced Solid Tumor
  • APL-102 Capsules
  • Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
Sep 14, 2021

Breast Cancer, Prehabilitation, Physical Activity Trial in Hershey (Exercise, Prehabilitation Education)

Completed
  • Breast Cancer
  • +3 more
  • Exercise
  • Prehabilitation Education
  • Hershey, Pennsylvania
    Penn State Cancer Institute
Jan 7, 2020

Resectable Pancreatic Cancer Trial in Hangzhou (iNeo-Vac-P01, GM-CSF)

Recruiting
  • Resectable Pancreatic Cancer
  • iNeo-Vac-P01
  • GM-CSF
  • Hangzhou, Zhejiang, China
    Zhejiang Provincial People's Hospital
Nov 15, 2021

Pancreatic Cancer, Pancreatic Carcinoma Trial in Hangzhou (iNeo-Vac-P01, GM-CSF)

Completed
  • Pancreatic Cancer
  • Pancreatic Carcinoma
  • iNeo-Vac-P01
  • GM-CSF
  • Hangzhou, Zhejiang, China
    Zhejiang Provincial People's Hospital
Nov 15, 2021

1st-line or 2nd-line Chemotherapy for HER2-negative

Completed
  • Breast Cancer
  • Kobe-city, Hyogo-prefecture, Japan
  • +1 more
Jun 10, 2021

Cancer, Palliative Radiotherapy Trial in Saint Louis (Lattice stereotactic body radiation therapy, Peripheral blood)

Completed
Has Results
  • Cancer
  • Palliative Radiotherapy
  • Lattice stereotactic body radiation therapy
  • Peripheral blood
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 22, 2021

Pharmacokinetics Trial in Helsinki (Placebo, Ticagrelor, Rosuvastatin)

Recruiting
  • Pharmacokinetics
  • Placebo
  • +2 more
  • Helsinki, Finland
    Department of Clinical Pharmacology
May 10, 2022

Cholangiocarcinoma Trial in Düsseldorf (Combination of Lonsurf® and Irinotecan)

Recruiting
  • Cholangiocarcinoma
  • Combination of Lonsurf® and Irinotecan
  • Düsseldorf, NRW, Germany
    Klinik für Gastroenterologie, Hepatologie und Infektiologie
Dec 22, 2022

Pancreatic Cancer Trial in Seoul (cell free DNA in blood, genetic mutation in tissue)

Recruiting
  • Pancreatic Cancer
  • cell free DNA in blood, genetic mutation in tissue
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Nov 2, 2022

Salivary Interleukin-32, Interleukin-10, Interleukin-6 and Tumor

Completed
  • Early Childhood Caries
  • ELISA
  • Aydın, Turkey
    Sultan KELEŞ
Oct 20, 2021

Clinical, Histological and Prognostic Forms of Adenocarcinoma of

Active, not recruiting
  • Anal Adenocarcinoma
    • Paris, France
    • +1 more
    Nov 7, 2022

    Melanoma, Unresectable (Stage III) Melanoma, Metastatic (Stage IV) Melanoma Trial in United States (Omaveloxolone Capsules (2.5

    Completed
    Has Results
    • Melanoma
    • +2 more
    • Omaveloxolone Capsules (2.5 mg/capsule)
    • +4 more
    • Mobile, Alabama
    • +9 more
    Jun 4, 2021

    Carcinoma, Melanoma, Bladder Cancer Trial in Chengdu (Tumor antigen-sensitized DC vaccine and their sensitized T cells

    Not yet recruiting
    • Carcinoma
    • +3 more
    • Tumor antigen-sensitized DC vaccine and their sensitized T cells subcutaneous administration
    • Chengdu, Sichuan, China
      West China Hospital
    Feb 10, 2022

    NSCLC (NSCLC) Trial in Tianjin (IBI110, sintilimab)

    Recruiting
    • Non-small Cell Lung Cancer (NSCLC)
    • Tianjin, Tianjin, China
      Tianjin Medical University Cancer Institute and Hospital
    Dec 26, 2021

    Breast Cancer Trial in Cranberry Township, Pittsburgh (Contrast-enhanced mammography, Iodinated Contrast Media (ICM))

    Recruiting
    • Breast Cancer
    • Contrast-enhanced mammography
    • Iodinated Contrast Media (ICM)
    • Cranberry Township, Pennsylvania
    • +2 more
    Jan 5, 2022

    Prostate Cancer Trial in Beijing (2.0 GBq of 177Lu-EB-PSMA)

    Recruiting
    • Prostate Cancer
    • 2.0 GBq of 177Lu-EB-PSMA
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Jul 13, 2022

    Melanoma Trial in United States (Ipilimumab, Nivolumab)

    Completed
    Has Results
    • Melanoma
    • Duarte, California
    • +35 more
    Sep 8, 2021

    Advanced Malignant Tumor, Locally Advanced Malignant Tumor Trial in Philadelphia (Counseling, Genetic Counseling, Genetic

    Completed
    • Advanced Malignant Neoplasm
    • Locally Advanced Malignant Neoplasm
    • Counseling
    • +4 more
    • Philadelphia, Pennsylvania
      ECOG-ACRIN Cancer Research Group
    Jul 30, 2021

    Tumors With Aberrations in ALK or ROS1 Trial in United States (Ceritinib)

    Terminated
    Has Results
    • Tumors With Aberrations in ALK or ROS1
    • Santa Rosa, California
    • +20 more
    Mar 12, 2021

    Prostate Cancer Trial in Canada, United States (bicalutamide, estramustine phosphate sodium, etoposide)

    Completed
    Has Results
    • Prostate Cancer
    • Birmingham, Alabama
    • +53 more
    Oct 19, 2020

    Retroperitoneal Tumors Trial in Cluj-Napoca (CEUS-guided percutaneous biopsy, B-mode US-guided percutaneous biopsy)

    Completed
    • Retroperitoneal Neoplasms
    • CEUS-guided percutaneous biopsy
    • B-mode US-guided percutaneous biopsy
    • Cluj-Napoca, Cluj County, Romania
      Prof. Dr. O. Fodor Regional Institute of Gastroenterology and He
    Dec 12, 2022

    Metastatic Cancer, Solid Tumor Trial in Bayonne, Bordeaux, Pessac (computed tomography, positron emission tomography,

    Completed
    Has Results
    • Metastatic Cancer
    • Unspecified Adult Solid Tumor, Protocol Specific
    • computed tomography
    • +2 more
    • Bayonne, France
    • +2 more
    Mar 8, 2022

    Advanced Solid Tumors Trial (c610 injection)

    Not yet recruiting
    • Advanced Solid Tumors
    • c610 injection
    • (no location specified)
    Oct 7, 2023

    Malignant Solid Tumors Trial (T60c injection)

    Not yet recruiting
    • Malignant Solid Tumors
    • T60c injection
    • (no location specified)
    Oct 7, 2023